Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jun 5, 2023 (3 years ago)

Arnica 7 Cream

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP deviations

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Arnica 7 Cream, net wt 2 oz (56.7g), Manufactured for: Brazmedics, LLC, New York, NY 10021 UPC 8 60208 00181 6

Drug: Arnica

Recalling firm
Homeocare Laboratories, Inc.
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0881-2023 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Arnica recalls

See all
Class II · Moderate risk

ZTE-1035 Formula

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Terminated Failed specification Washington Homeopathic Products, Inc. D-0886-2021

Other recalls by Homeocare Laboratories, Inc.

All 2023 recalls